Are you Dr. Torti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
263 Farmington Ave
Hematology/Oncology
Farmington, CT 06030Phone+1 860-679-2100Fax+1 860-679-4815
Summary
- Dr. Frank Torti, MD is an oncologist in Farmington, Connecticut. He is currently licensed to practice medicine in Connecticut, North Carolina, and California. He is affiliated with UConn, John Dempsey Hospital and is a Professor of Medicine at Wake Forest University.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1978 - 1979
Harvard Medical SchoolClass of 1974
Certifications & Licensure
CA State Medical License 1977 - Present
CT State Medical License 2012 - 2025
NC State Medical License 1994 - 2013
CO State Medical License 1976 - 1983
Clinical Trials
- Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium Start of enrollment: 1998 Jun 01
- Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy Start of enrollment: 2006 Feb 01
- Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2004 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 381 citationsFerritin for the ClinicianMary Ann Knovich, Jonathan A. Storey, Lan G. Coffman, Suzy V. Torti, Frank M. Torti
Blood Reviews. 2009-05-01 - 4009 citationsFerroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseBrent R. Stockwell, José Pedro Friedmann Angeli, Hülya Bayır, Ashley I. Bush, Marcus Conrad
Cell. 2017-10-05 - 801 citationsRegulation of ferritin genes and proteinFrank M. Torti, Suzy V. Torti
Blood. 2002-05-15
Press Mentions
15 Facts at 15 WeeksSeptember 9th, 2021
Myovant Sciences Confirms Closing of US$400 Million Loan FacilityJanuary 6th, 2020
Respivant Sciences Opens with Focus on Treating Chronic Cough in IPF PatientsSeptember 24th, 2018- Join now to see all
Professional Memberships
- Member
